摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,4R,5S)-2-(aminomethyl)piperidine-3,4,5-triol | 1207673-09-3

中文名称
——
中文别名
——
英文名称
(2R,3S,4R,5S)-2-(aminomethyl)piperidine-3,4,5-triol
英文别名
——
(2R,3S,4R,5S)-2-(aminomethyl)piperidine-3,4,5-triol化学式
CAS
1207673-09-3
化学式
C6H14N2O3
mdl
——
分子量
162.189
InChiKey
BZJDIVJXNTYEOB-DPYQTVNSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    341.1±42.0 °C(Predicted)
  • 密度:
    1.372±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    98.7
  • 氢给体数:
    5
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    (2R,3S,4R,5S)-2-(aminomethyl)piperidine-3,4,5-triol3-(4-氯苯甲酰)丙酸 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 二甲基亚砜 为溶剂, 反应 24.0h, 生成
    参考文献:
    名称:
    合成(3 S,4 S,5 S)-三羟基哌啶衍生物作为酶稳定剂以改善法布里(Fabry)患者细胞系中的治疗性酶活性
    摘要:
    合成并测试了一系列在C-2或C-6位置具有结构多样性的3 S,4 S,5 S-三羟基化哌啶,以确定其稳定重组人α-半乳糖苷酶A(rh-α -加仑A)。通过快速抑制活性筛选鉴定出命中分子,然后进一步研究其保护该酶免受热诱导变性并增强其在Fabry患者细胞系中活性的能力。我们的研究导致鉴定出一类新的小分子作为酶稳定剂,可用于治疗法布里疾病。其中,稳定剂21最有效,在Fabry疾病细胞系中rh-α-GalA活性提高了12倍。
    DOI:
    10.1016/j.ejmech.2017.12.036
  • 作为产物:
    描述:
    盐酸 、 palladium carbon (20 wt%) 、 氢气 作用下, 以 甲醇 为溶剂, 反应 25.0h, 以138 mg的产率得到(2R,3S,4R,5S)-2-(aminomethyl)piperidine-3,4,5-triol
    参考文献:
    名称:
    合成(3 S,4 S,5 S)-三羟基哌啶衍生物作为酶稳定剂以改善法布里(Fabry)患者细胞系中的治疗性酶活性
    摘要:
    合成并测试了一系列在C-2或C-6位置具有结构多样性的3 S,4 S,5 S-三羟基化哌啶,以确定其稳定重组人α-半乳糖苷酶A(rh-α -加仑A)。通过快速抑制活性筛选鉴定出命中分子,然后进一步研究其保护该酶免受热诱导变性并增强其在Fabry患者细胞系中活性的能力。我们的研究导致鉴定出一类新的小分子作为酶稳定剂,可用于治疗法布里疾病。其中,稳定剂21最有效,在Fabry疾病细胞系中rh-α-GalA活性提高了12倍。
    DOI:
    10.1016/j.ejmech.2017.12.036
点击查看最新优质反应信息

文献信息

  • CYCLIC CARBODIIMIDE COMPOUNDS
    申请人:Shoji Shinichiro
    公开号:US20110251384A1
    公开(公告)日:2011-10-13
    A cyclic carbodiimide compound which is useful as an end-sealing agent for polymer compounds. The cyclic carbodiimide compound is represented by the following formula (i): In the above formula, X is a divalent group or a tetravalent group represented by the following formula (i-4). When X is divalent, q is 0 and when X is tetravalent, q is 1. Ar 1 to Ar 4 are each independently an aromatic group. They may be substituted by an alkyl group having 1 to 6 carbon atoms or phenyl group.
    一种环状羰基胺化合物,可用作聚合物化合物的端封剂。该环状羰基胺化合物由以下式(i)表示:在上述式中,X是由以下式(i-4)表示的二价基团或四价基团。当X为二价时,q为0;当X为四价时,q为1。Ar1至Ar4分别是独立的芳香基团。它们可以被具有1至6个碳原子的烷基基团或苯基取代。
  • CYCLIC CARBODIIMIDE COMPOUND
    申请人:Shoji Shinichiro
    公开号:US20130079510A1
    公开(公告)日:2013-03-28
    Disclosed is a cyclic carbodiimide compound useful as an end-capping agent for polymer compounds. The cyclic carbodiimide compound is represented by the following formula (i): wherein X is a specific divalent group or tetravalent group, q is 0 when X is a divalent group, while q is 1 when X is a tetravalent group, and Ar 1 to Ar 4 are selected from aromatic groups each independently optionally substituted with a group that serves as X.
    揭示了一种循环脲醛化合物,可用作聚合物化合物的末端封端剂。该循环脲醛化合物由以下式(i)表示:其中X是特定的二价基团或四价基团,当X是二价基团时,q为0,而当X是四价基团时,q为1,Ar1至Ar4选择自各自独立地可选择地取代为X的基团的芳香族基团。
  • Highly aromatic polyurea/urethane membranes and their use for separating aromatics from non-aromatics
    申请人:EXXON RESEARCH AND ENGINEERING COMPANY
    公开号:EP0312374A2
    公开(公告)日:1989-04-19
    Novel membranes, useful for the separation of aromatics from mixtures thereof with non-aromatics, in, for example, a naphtha feed stream, are characterized by possessing a urea index of at least about 20% but less than 100%, an aromatic carbon content of at least about 15 mole percent, a functional group density of at least about 10 per 1000 grams of polymer and a C = O/NH ratio of less than about 8.0. These highly aromatic polyurea/urethane membranes are symmetric, dense film membranes made from the corresponding polyurea/urethane copolymers by standard membrane casting techniques. The polyurea/urethane copolymers are preferably produced by reacting dihydroxy or polyhydroxy compounds, such as polyethers or polyesters having molecular weights in the range of about 500 to 5000 with aliphatic, alkylaromatic or aromatic diisocyanates or polyisocyanates and low molecular weight chain extenders, such as diamines, polyamines or amino alcohols. The membranes are useful for separating aromatics from non-aromatics in e.g., petroleum refining and chemical applications.
    新型膜可用于从例如石脑油进料流中的芳烃与非芳烃混合物中分离芳烃,其特点是脲指数至少约为 20%,但小于 100%,芳香碳含量至少约为 15 摩尔%,官能团密度至少约为每 1000 克聚合物 10 个,C = O/NH 比率小于约 8.0。这些高芳香族聚脲/聚氨酯膜是由相应的聚脲/聚氨酯共聚物通过标准膜铸造技术制成的对称致密膜。聚脲/聚氨酯共聚物最好是通过二羟基或多羟基化合物(如分子量在 500 至 5000 之间的聚醚或聚酯)与脂肪族、烷芳香族或芳香族二异氰酸酯或多异氰酸酯以及低分子量扩链剂(如二胺、多胺或氨基醇)反应制得。 这些膜可用于分离芳烃和非芳烃,如石油精炼和化工应用。
  • Medical devices having a coating of amine rich fluorinated polyurethaneurea and an antithrombogenic agent covalently bonded thereto and method for their preparation
    申请人:Becton Dickinson and Company
    公开号:EP0404515A2
    公开(公告)日:1990-12-27
    A thermoplastic polyurethaneurea having free amino groups and comprising a product from the reaction of a diisocyanate, a polyamine and a misture of polyols comprising a fluorinated polyol and a non-fluorinated polyol selected from polyalkyleneoxide polyols and polyester polyols. A medical device having a hemocompatible surface comprising a shaped polymeric article having thereon a coating of a thermoplastic polyurethaneurea as claimed in Claim 1, and an antithrombogenic agent covalently affixed to amino groups of the polyurethaneurea coating.
    一种具有游离氨基基团的热塑性聚氨酯脲,它包括二异氰酸酯、多胺和多元醇反应的产物,多元醇包括从聚亚烷基氧化物多元醇和聚酯多元醇中选出的含氟多元醇和非含氟多元醇。一种具有血液相容性表面的医疗器械,包括一个成型的聚合物制品,其上有一层如权利要求1所述的热塑性聚氨酯涂层,以及一种共价连接到聚氨酯涂层氨基上的抗血栓形成剂。
  • Thermoplastic elastomer hydrophilic polyetherurethane expandable catheter
    申请人:Superior Healthcare Group, Inc.
    公开号:EP0404517A1
    公开(公告)日:1990-12-27
    A melt extruded cathether of thermoplastic elastomeric hydrophilic polyurethane synthesized from a diisocyanate, a polyglycol component comprising a polyethyleneoxide glycol of high molecular weight and a chain extender expands to a larger lumen size when contacted with an aqueous liquid. The catheter may include an antithrombogenic agent, antiinfective agent and radiopaque agent. The hydrophilic polyurethane may be synthesized by one-shot bulk polymerization, and may be melt extruded into the catheter tubing, and may encapsulate a stripe of a stiffening polyurethane.
    一种由二异氰酸酯合成的热塑性弹性亲水聚氨酯、由高分子量的聚乙二醇和扩链剂组成的聚乙二醇组分熔融挤出的导管,在与水性液体接触时会膨胀成较大的管腔尺寸。导管可包括抗血栓形成剂、抗感染剂和不透射线剂。亲水性聚氨酯可通过一次块状聚合合成,并可熔融挤压到导管管材中,还可包裹硬质聚氨酯条纹。
查看更多